Target intelligence / Profile preview

ARF like GTPase 4A pseudogene 1 (ARL4AP1)

Target
ARL4AP1
Molecular classification
Pseudogene, ADP-ribosylation factor-like family
01

Overview

ARL4AP1 is a pseudogene related to the ARF like GTPase 4A (ARL4A) gene. Pseudogenes are stretches of DNA resembling functional genes but generally lack the ability to code for active proteins. In some cases, pseudogenes can serve as regulators of other genes through RNA interference or microRNA decoy mechanisms, influencing expression of their corresponding coding genes. Currently, there is no direct evidence that ARL4AP1 has biological function or involvement in disease, nor is it considered a therapeutic target. Its parental gene, ARL4A, encodes a small GTP-binding protein involved in cellular signaling and is associated with non-syndromic X-linked intellectual disability, but these features do not extend to the pseudogene[1][2][5]. Key clarification: ARL4AP1 is not a receptor, enzyme, transporter, or any canonical therapeutic target. As a pseudogene, it does not produce a functional protein. The gene is correctly identified as a pseudogene rather than a genuine molecular target relevant for drug intervention, safety, or biomarker usage[2][5].

Other names
Em:AC022390.2similar to ADP-ribosylation factor-like protein 4
02

Biological functions

While pseudogenes do not encode functional proteins, they can regulate their parental coding genes via RNA interference mechanisms or serve as miRNA decoys in certain biological contexts[2][5]. However, no specific functional regulatory evidence exists for ARL4AP1.
03

Disease associations

Pseudogenes can play roles in diseases by modulating coding gene expression, but there is no documented association of ARL4AP1 with any disease[2][5].

Beyond the preview

Go deeper on ARF like GTPase 4A pseudogene 1 (ARL4AP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ARF like GTPase 4A pseudogene 1 (ARL4AP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call